NL
DE
8 January 2018
Non-muscle invasive bladder cancer patients (NMIBC) with T1 tumours or genomically unstable/squamous-cell-carcinoma-like molecular subtypes have a high risk of recurrence and muscle-invasive progression, the latter being a life-threatening condition. This project will provide insight in whether associations of smoking, body weight, physical activity, and fruit and vegetable consumption with NMIBC outcomes are mediated and/or modified by tumour stage and molecular subtype. Our ultimate aim is to provide NMIBC patients with tailored advice concerning their lifestyle to enable them to influence their prognosis.
Collaboration between Radboudumc (Project Leader Alina Vrieling, Principal Investigator Bart Kiemeney) and Erasmus MC (Principal Investigator Dr. Arno van Leenders)
Lifestyle habits and bladder cancer prognosis: effects by tumour stage and molecular subtype.
Non-muscle invasive bladder cancer patients (NMIBC) with T1 tumours or genomically unstable/squamous-cell-carcinoma-like molecular subtypes have a high risk of recurrence and muscle-invasive progression, the latter being a life-threatening condition. This project will provide insight in whether associations of smoking, body weight, physical activity, and fruit and vegetable consumption with NMIBC outcomes are mediated and/or modified by tumour stage and molecular subtype. Our ultimate aim is to provide NMIBC patients with tailored advice concerning their lifestyle to enable them to influence their prognosis.
Collaboration between Radboudumc (Project Leader Alina Vrieling, Principal Investigator Bart Kiemeney) and Erasmus MC (Principal Investigator Dr. Arno van Leenders)
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Body composition is more important than BMI for renal cancer survival rates
11 January 2022 Body composition is important for survival rates in renal cell cancer. Research from the Radboudumc shows that low muscle quality and low organ fat are associated with poor survival. This involves different stages of renal cancer, ranging from stage I-III to stage IV. read more
Millions of euros for study of laser treatment for glioblastoma
2 April 2021 A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care. read more
Guiding the surgeon real-time tumor visualization during surgery
26 February 2020 Incomplete excision of tumor tissue negatively affects the prognosis of the patient. RIHS researcher Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic. read more
Identification of dozens of ovarian cancer genes
21 August 2018 In Cancer Research, a global consortium in which Leon Massuger and Bart Kiemeney participate describes the identification of dozens of low-penetrance genes at genomic loci that were previously associated with ovarian cancer. read more
